Found: 187
Select item for more details and to access through your institution.
Joint EANM-SNMMI guidelines on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Joint EANM-SNMMI guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 9, p. 2706, doi. 10.1007/s00259-024-06696-9
- By:
- Publication type:
- Article
Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of <sup>99m</sup>Tc and <sup>188</sup>Re Theranostic Agents for Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1087, doi. 10.2967/jnumed.124.267450
- By:
- Publication type:
- Article
The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years (2020–2070).
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60649-8
- By:
- Publication type:
- Article
Clinical [ 18 F]FSPG Positron Emission Tomography Imaging Reveals Heterogeneity in Tumor-Associated System x c − Activity.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1437, doi. 10.3390/cancers16071437
- By:
- Publication type:
- Article
Is System x c − a Suitable Target for Tumour Detection and Response Assessment with Imaging?
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5573, doi. 10.3390/cancers15235573
- By:
- Publication type:
- Article
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad077
- By:
- Publication type:
- Article
Deep Learned Segmentations of Inflammation for Novel ⁹⁹ m Tc-maraciclatide Imaging of Rheumatoid Arthritis.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 21, p. 3298, doi. 10.3390/diagnostics13213298
- By:
- Publication type:
- Article
Utility of a simplified [<sup>18</sup>F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1236881
- By:
- Publication type:
- Article
Inter-rater and intra-rater agreement of [<sup>99m</sup>Tc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-01002-4
- By:
- Publication type:
- Article
[<sup>99m</sup>Tc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-00990-7
- By:
- Publication type:
- Article
Input function and modeling for determining bone metabolic flux using [<sup>18</sup>F] sodium fluoride PET imaging: A step-by-step guide.
- Published in:
- Medical Physics, 2023, v. 50, n. 4, p. 2071, doi. 10.1002/mp.16125
- By:
- Publication type:
- Article
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99</sup>mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 227, doi. 10.2967/jnumed.122.264296
- By:
- Publication type:
- Article
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6056, doi. 10.3390/cancers14246056
- By:
- Publication type:
- Article
Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT.
- Published in:
- Insights into Imaging, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13244-022-01245-0
- By:
- Publication type:
- Article
A Phase II, Open‐label study to assess safety and management change using <sup>68</sup>Ga‐THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.257527
- By:
- Publication type:
- Article
A Phase II, Open‐label study to assess safety and management change using <sup>68</sup>Ga‐THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.257527
- By:
- Publication type:
- Article
Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [<sup>99m</sup>Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Systematic review of research design and reporting of imaging studies applying convolutional neural networks for radiological cancer diagnosis.
- Published in:
- European Radiology, 2021, v. 31, n. 10, p. 7969, doi. 10.1007/s00330-021-07881-2
- By:
- Publication type:
- Article
A Phase II, Open‐label study to assess safety and management change using <sup>68</sup>Ga‐THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.257527
- By:
- Publication type:
- Article
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.257527
- By:
- Publication type:
- Article
Optimisation of CT protocols in PET-CT across different scanner models using different automatic exposure control methods and iterative reconstruction algorithms.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00404-4
- By:
- Publication type:
- Article
Standardisation of conventional and advanced iterative reconstruction methods for Gallium-68 multi-centre PET-CT trials.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00400-8
- By:
- Publication type:
- Article
Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 8, p. 2558, doi. 10.1007/s00259-020-05182-2
- By:
- Publication type:
- Article
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.257527
- By:
- Publication type:
- Article
CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.13_2880
- By:
- Publication type:
- Article
THE MUTATIONAL LANDSCAPE OF DOUBLE/TRIPLE‐HIT HIGH‐GRADE B‐CELL LYMPHOMA WITH BCL2 REARRANGEMENT (DH/TH‐BCL2) – AN LLMPP PROJECT.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.65_2879
- By:
- Publication type:
- Article
THE TOPOLOGY OF MYC REARRANGEMENTS IN DOUBLE‐HIT LYMPHOMA IS CONSTRAINED BY THE PRECEDING IGH‐BCL2 REARRANGEMENT – AN LLMPP PROJECT.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.64_2879
- By:
- Publication type:
- Article
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 32, doi. 10.2967/jnumed.120.257527
- By:
- Publication type:
- Article
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.257527
- By:
- Publication type:
- Article
Inter- and intraobserver agreement of the quantitative assessment of [<sup>99m</sup>Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00734-x
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
Molecular imaging of bone metastases and their response to therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.234260
- By:
- Publication type:
- Article
The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 3, p. 674, doi. 10.1007/s00259-019-04643-7
- By:
- Publication type:
- Article
Performance of <sup>18</sup>F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
What can artificial intelligence teach us about the molecular mechanisms underlying disease?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 13, p. 2715, doi. 10.1007/s00259-019-04370-z
- By:
- Publication type:
- Article
Untitled.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.226555
- By:
- Publication type:
- Article
Early phase I study of a <sup>99m</sup>Tc labeled anti-PD-L1 single domain antibody in SPECT/CT assessment of programmed death ligand-1 expression in non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224170
- By:
- Publication type:
- Article
Adaptive statistical iterative reconstruction (ASIR) affects CT radiomics quantification in primary colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1213, doi. 10.2967/jnumed.118.224170
- By:
- Publication type:
- Article
Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV<sub>max</sub> in [<sup>18</sup>F]fluoride and [<sup>18</sup>F]FDG PET?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Exploratory radiomic features from integrated <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1478, doi. 10.1007/s00259-019-04306-7
- By:
- Publication type:
- Article
Radiomics in esophageal and gastric cancer.
- Published in:
- Abdominal Radiology, 2019, v. 44, n. 6, p. 2048, doi. 10.1007/s00261-018-1724-8
- By:
- Publication type:
- Article